Growth Metrics

Novartis Ag (NVS) Long-Term Investments (2016 - 2026)

Novartis Ag's Long-Term Investments history spans 15 years, with the latest figure at $100.0 million for Q1 2026.

  • On a quarterly basis, Long-Term Investments fell 12.28% to $100.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $100.0 million, a 12.28% decrease, with the full-year FY2025 number at $98.0 million, down 17.65% from a year prior.
  • Long-Term Investments hit $100.0 million in Q1 2026 for Novartis Ag, up from $98.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for NVS hit a ceiling of $2.4 billion in Q2 2022 and a floor of $46.0 million in Q1 2023.
  • Historically, Long-Term Investments has averaged $615.5 million across 5 years, with a median of $143.0 million in 2022.
  • Biggest five-year swings in Long-Term Investments: tumbled 76.41% in 2023 and later soared 106.52% in 2024.
  • Tracing NVS's Long-Term Investments over 5 years: stood at $143.0 million in 2022, then soared by 43.36% to $205.0 million in 2023, then crashed by 41.95% to $119.0 million in 2024, then fell by 17.65% to $98.0 million in 2025, then increased by 2.04% to $100.0 million in 2026.
  • Business Quant data shows Long-Term Investments for NVS at $100.0 million in Q1 2026, $98.0 million in Q4 2025, and $85.0 million in Q3 2025.